Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Ahead of an FDA Decision, Do You Buy This Stock?
Motley Fool
Sunday, July 14, 2013 - 11:23am
tags:
Pharmacyclics
Alexion valuation could choke any Roche bid
Yahoo/Reuters
Sunday, July 14, 2013 - 11:22am
tags:
Alexion, Roche, M&A
Who Could Buy Onyx and at What Price?
Motley Fool
Sunday, July 14, 2013 - 11:21am
tags:
Onyx, M&A, Amgen, Bayer, Celgene
This Week in Biotech
Motley Fool
Sunday, July 14, 2013 - 11:19am
tags:
Pharmacyclics, JNJ, Alnylam, Inovio, Alexion, Roche
Sun Pharma gets USFDA nod for generic diabetes tablets
Zee News, India
Saturday, July 13, 2013 - 12:43pm
tags:
Sun Pharma, diabetes, repaglinide, Prandin, Novo Nordisk, generics
ALK's phase III MITRA trial of new allergy immunotherapy tablet against house dust mite-induced allergic asthma meets primary endpoint
Pharmabiz
Saturday, July 13, 2013 - 12:41pm
tags:
asthma, Merck, ALK-Abello
FDA approves GILOTRIF™ (afatinib) as first-line treatment for metastatic non-small cell lung cancer with common EGFR mutations
Sacramento Bee, CA
Saturday, July 13, 2013 - 12:37pm
tags:
non-small cell lung cancer, Gilotrif, Afatinib, Boehringer Ingelheim
Elder Pharma jumps on board's nod for business restructuring
Business Standard, India
Saturday, July 13, 2013 - 12:35pm
tags:
Elder Pharmaceuticals
Potential for Deals Drives a Big Surge in the Biotech Sector
NY Times
Saturday, July 13, 2013 - 12:35pm
tags:
M&A
Can GlaxoSmithKline Break Higher?
Wall Street Cheat Street
Saturday, July 13, 2013 - 12:32pm
tags:
GSK
Anthera Pharmaceuticals announces 1-for-8 reverse stock split
Yahoo/the fly on the wall
Saturday, July 13, 2013 - 12:31pm
tags:
Anthera
A Developing "Breakthrough" In Biotechnology that You Should Monitor
Motley Fool
Saturday, July 13, 2013 - 12:31pm
tags:
Pharmacyclics, ibrutinib, blood cancer, JNJ, AbbVie
Diovan Data Was Fabricated, Say Japanese Health Minister And University Officials
Forbes
Saturday, July 13, 2013 - 12:10pm
tags:
Diovan, Novartis
BMY/Pfizer Seek to Expand Eliquis Label
Yahoo/Zacks
Saturday, July 13, 2013 - 12:09pm
tags:
Eliquis, Bristol-Myers Squibb, Pfizer, deep vein thrombosis
Lilly Goes All In On Solanezumab
Seeking Alpha
Saturday, July 13, 2013 - 12:07pm
tags:
Eli Lilly, solanezumab, Alzheimer's disease
Eli Lilly's Management Hosts Update on Solanezumab Call (Transcript)
Yahoo/Seeking Alpha
Saturday, July 13, 2013 - 12:07pm
tags:
Eli Lilly, solanezumab, Alzheimer's disease
Pet Diagnostics Grow Faster than Other Segments of the Animal Care Sector: How Does Human and Animal Care Relate and Differ? Which is a Better Ingredient for Your Portfolio?
Wall Street Transcript
Saturday, July 13, 2013 - 12:05pm
tags:
Broker Darlings of the Dow: Johnson & Johnson Ranks As a Top 15 Analyst Pick
Forbes
Saturday, July 13, 2013 - 12:04pm
tags:
JNJ
Large-Cap Pharmaceutical Stocks Continue to Show Attractive Yields: An Exclusive Interview with Expert Money Managers Reveals an Investment Philosophy Focused on Dividend-Paying Companies
Wall Street Transcript
Saturday, July 13, 2013 - 12:03pm
tags:
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, July 13, 2013 - 12:02pm
tags:
Merrimack Pharmaceuticals, GTx, Intuitive Surgical

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.